Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation-Reference-Cited by-同舟云学术

Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation

Published:2021-01 Issue:1 Volume:27 Page:58-66
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Epperla Narendranath,Ahn Kwang W.,Khanal Manoj,Litovich Carlos,Ahmed Sairah,Ghosh Nilanjan,Fenske Timothy S.,Kharfan-Dabaja Mohamed A.,Sureda Anna,Hamadani Mehdi

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference30 articles.

1. Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma;Epperla;J Hematol Oncol,2017

2. Reduced-intensity allografting as first transplantation approach in relapsed/refractory grades one and two follicular lymphoma provides improved outcomes in long-term survivors;Klyuchnikov;Biol Blood Marrow Transplant,2015

3. Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors;Kanate;Blood,2016

4. Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and Marrow Transplant Research analysis;Ghosh;J Clin Oncol,2016

5. Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation;Fenske;Br J Haematol,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2024-07-24

2. Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years;Blood Cancer Journal;2024-07-05

3. Minimalist approach to conditioning intensity for allogeneic transplantation of patients with non-Hodgkin Lymphoma: if less is more, than how low do we go?;Transplantation and Cellular Therapy;2024-01

4. Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy;Bone Marrow Transplantation;2023-12-16

5. Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma;Bone Marrow Transplantation;2023-12-15